NAUSEA RX

WELCOME TO NAUSEARX.COM

NAUSEARX.COM is pharmacy-education English: Nausea Rx—specialty pharmacies, oncology support desks, and med-ed publishers that already say “nausea Rx” when they mean antiemetic literacy. Nausea lane—not MucusRx respiratory or MouthRx oral doors.

Best-fit buyers: specialty pharmacies; oncology support publishers; med-ed brands; defensive holders. Exact-fit launch: a Nausea Rx education hub with therapy-class tiles, clinician FAQ, and “not medical advice” footer.

ASHP reports U.S. prescription drug spending of $915.2 billion in 2025 (+12.7%), with a trajectory above $1 trillion in 2026—the Rx-spend spine behind specialty education brands.^[1] CDC notes U.S. adults average 2–3 colds per year—the everyday illness backdrop that still drives antiemetic and supportive-care conversations adjacent to nausea literacy.^[2] That Rx spine frames why exact Nausea Rx inventory matters—not an invented category TAM.

Why Choose NAUSEARX.COM

• 💊 Nausea Rx lockup: Antiemetic education English already spoken.
• 📊 Rx-spend spine: U.S. Rx $915.2B in 2025 (ASHP).^[1]
• 🤧 Illness adjacency: Adults average 2–3 colds/year (CDC).^[2]
• 🔍 Vs MucusRx: Nausea antiemetic ≠ mucus/respiratory door.
• 🔍 Vs MouthRx: Systemic nausea literacy ≠ oral/dental Rx.
• ✨ Desk clarity: Sounds like the specialty pharmacy education brand.

WHAT DOES ALAN ISAACS THINK?

"NauseaRx.com is pharmacy-education inventory—Nausea Rx, not MucusRx or MouthRx."

Alan Isaacs, Finance Manager

Contact Alan Isaacs via Email